Motor Neuron Disease (Kalra) Flashcards

1
Q

Classify weakness, bulk, fasciculations, tone, and reflexes in UMN vs LMN degeneration

A
  • weakness: UMN +, LMN +++
  • bulk: UMN normal, LMN atrophy
  • fasciculations: UMN absent, LMN present
  • tone: UMN increased, LMN decreased
  • reflexes: UMN increased, LMN decreased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

TRUE or FALSE: primary lateral sclerosis is purely LMN signs, and progressive muscular atrophy is purely UMN signs

A

FALSE: primary lateral sclerosis = UMN; progressive muscular atrophy = LMN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Does ALS have UMN or LMN signs?

A

both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does amyotrophy result from?

A

loss of anterior horn cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the most common idiopathic motor neuron disorder?

A

ALS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Who was the first person to describe concurrent upper and lower motor neuron pathology?

A

Charcot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When does onset of ALS occur? What is the male to female ratio?

A
  • anytime in adulthood (around 55 years)
  • male:female, 1.5:1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the risk factors for ALS?

A
  • age
  • smoking
  • service in armed forces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical features of ALS (i.e. bulbar, limb, respiratory) in general?

A

BULBAR:
- dysarthria
- dysphagia
- dysphonia
- labile affect

LIMB:
- weakness
- cramps
- stiffness

RESPIRATORY:
- resp muscles weaken…major cause of death from ALS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What functions are spared in ALS?

A
  • sensation
  • sphincter
  • (cognitive)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical features of upper and lower extremities in ALS?

A

UPPER EXTREMITY:
- hand - fine motor activities
- shoulder - proximal arm weakness; “frozen shoulder”
- axial - stooped posture

LOWER EXTREMITY:
- foot drop
- difficulty with chairs, stairs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the respiratory features of ALS?

A
  • dyspnea (shortness of breath)
  • orthopnea (difficulty breathing when lying down)
  • sleep disordered breathing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the frontotemporal features of ALS?

A
  • cognitive impairments - executive, language, social cognition
  • behavioural impairments - apathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In what ways does cognitive impairment affect individuals with ALS?

A
  • impact decision making capacity
  • reduce survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is there decreased grey matter or white matter in ALS? In which areas do you see these decreases?

A
  • decreased grey matter
  • bilateral motor cortex
  • left frontal/temporal cortex
  • ACC
  • left lenticular cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What gene expansion is associated with ALS?

17
Q

Degeneration of which part of the brain is associated with the extra-motor pathology of ALS?

A
  • frontotemporal lobar degeneration (FTLD)
  • neuronal loss, gliosis
  • superficial spongiform degeneration in layers II/III
18
Q

What is the molecular link between ALS and FTD?

A

TDP-43 protein

19
Q

What is the genetic link between ALS and FTD?

20
Q

What is a marker of neurointegrity that can be quantified in vivo? What does a decrease in this marker indicate?

A
  • NAA
  • decrease NAA = increase disease progression
21
Q

What are the 4 neuropathological stages of pathological TDP-43 distribution in ALS?

A
  • stage 1: motor cortex, bulbar and spinal somatomotor neurons
  • stage 2: reticular formation, precerebellar nuclei, thalamus
  • stage 3: prefrontal neocortex, basal ganglia
  • stage 4: anteromedial temporal lobe, hippocampal formation
22
Q

Describe the ALS-FTD spectrum and the PMA-ALS-PLS spectrum.

A

see slide 24

23
Q

What is the ALS Functional Rating Scale used for? What is the average decline? What percent change in slope is considered clinically meaningful?

A
  • important endpoint in contemporary clinical trials
  • measure of disability; monitor disease progression
  • average decline of 1.02 points/month
  • 20-25%
24
Q

What are challenges resulting from extreme heterogeneity?

A
  • delayed diagnosis
  • delayed treatment
  • unable to predict prognosis
  • unable to predict treatment response
  • clinical trial failures
25
How is ALS largely diagnosed? Describe the work up.
- largely diagnoised by ruling out other diseases - NCS/EMG --> rule out neuropathy, subclinical denervation, staging - MRI brain or cervical spine - blood tests - pulmonary function tests
26
What condition mimics ALS?
cervical spondylosis
27
What is the WHO definition of palliative care?
the active total care of the patient whose disease is not responsive to curative therapy
28
What are the principles of management of ALS?
- patient autonomy - holistic and team approach - patient participation in clinical trials - effective use of home and hospice care - close communication between all parties involved - PALLIATIVE CARE
29
What are the goals of ALS management?
maximize quality of life and quality of death
30
What are some disease modifying treatments for ALS? Describe each.
RILUZOLE - anti-glutamatergic - prolong survival 3-6 months EDARAVONE - anti-oxidant - slow disability 33% AMX0035 - phenylbutyrate + taurursodiol - reduces ER stress and mitochondrial dysfuntion - slow disability, prolong survival TOFERSON (miracle drug) - ASO - SOD1
31
How do you manage sialorrhea/salivation in ALS?
anticholinergics
32
Which drug can be used to manage pseudobulbar symtpoms, anxiety, and insomnia in ALS?
amitryptyline
33
What can BiPAP be used for in ALS?
- best intervention for respiratory support - provide + pressure
34
What is PEG used for in ALS?
feeding tube